Usefulness of Microalbuminuria Versus the Metabolic Syndrome as a Predictor of Cardiovascular Disease in Women and Men >40 Years of Age (from the Rancho Bernardo Study)

American Journal of Cardiology

Volumn 101, Issue 9, 2008, Pages 1275-1280

  Jassal, Simerjot Kaur ^a   Langenberg, Claudia ^b   von Mühlen, Denise ^a   Bergstrom, Jaclyn ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY RISK; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINURIA; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SEX FACTORS;

EID: 43049099274     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.12.030     Document Type: Article

References (30)

1. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation (1999), World Health Organization, Geneva
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
3. Valmadrid C.T., Klein R., Moss S.E., and Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160 (2000) 1093-1100
4. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., Halle J.P., Young J., Rashkow A., Joyce C., Nawaz S., and Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
5. Wachtell K., Ibsen H., Olsen M.H., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., Dahlof B., Devereux R.B., Beevers G., de Faire U., Fyhrquist F., Julius S., Kjeldsen S.E., Kristianson K., Lederballe-Pedersen O., Nieminen M.S., Okin P.M., Omvik P., Oparil S., Wedel H., Snapinn S.M., and Aurup P. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139 (2003) 901-906
6. Wachtell K., Palmieri V., Olsen M.H., Bella J.N., Aalto T., Dahlof B., Gerdts E., Wright Jr. J.T., Papademetriou V., Mogensen C.E., Borch-Johnsen K., Ibsen H., and Devereux R.B. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 143 (2002) 319-326
7. Ravera M., Ratto E., Vettoretti S., Viazzi F., Leoncini G., Parodi D., Tomolillo C., Del Sette M., Maviglio N., Deferrari G., and Pontremoli R. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J Nephrol 15 (2002) 519-524
8. Bianchi S., Bigazzi R., and Campese V.M. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 34 (1999) 973-995
9. Yuyun M.F., Khaw K.T., Luben R., Welch A., Bingham S., Day N.E., and Wareham N.J. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol 159 (2004) 284-293
10. Diercks G.F., van Boven A.J., Hillege H.L., Janssen W.M., Kors J.A., de Jong P.E., Grobbee D.E., Crijns H.J., and van Gilst W.H. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 21 (2000) 1922-1927
11. Criqui M.H., Barrett-Connor E., and Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 108 (1978) 367-372
12. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 111 (1980) 705-712
13. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
14. Rose G.A., Blackburn H., Gillum R.F., and Prineas R.J. Cardiovascular Survey Methods. 2nd edition (1982), World Health Organization, Geneva 162-165
15. The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 5 (1976) 207-215
16. Lipid Research Clinics Program. Manual of Laboratory Operations (1974), National Institutes of Health, US Dept of Health, Education and Welfare, Bethesda 75-628
17. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1976) 499-502
18. Keane W.F., and Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33 (1999) 1004-1010
19. Dyer A.R., Greenland P., Elliott P., Daviglus M.L., Claeys G., Kesteloot H., Ueshima H., and Stamler J. Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 160 (2004) 1122-1131
20. Houlihan C.A., Tsalamandris C., Akdeniz A., and Jerums G. Albumin to creatinine ratio: a screening test with limitations. Am J Kidney Dis 39 (2002) 1183-1189
21. Weiner D.E., and Sarnak M.J. Microalbuminuria: a marker of cardiovascular risk. Am J Kidney Dis 42 (2003) 596-598
22. Tuttle K.R., Puhlman M.E., Cooney S.K., and Short R. Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study. Am J Kidney Dis 34 (1999) 918-925
23. Zandbergen A.A., Sijbrands E.J., Lamberts S.W., and Bootsma A.H. Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease. Diabetes Care 29 (2006) 1851-1855
24. Ko G.T., So W.Y., Chan N.N., Chan W.B., Tong P.C., Li J., Yeung V., Chow C.C., Ozaki R., Ma R.C., Cockram C.S., and Chan J.C. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome. Diabetes Obes Metab 8 (2006) 94-104
25. Stehouwer C.D., Nauta J.J., Zeldenrust G.C., Hackeng W.H., Donker A.J., and den Ottolander G.J. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340 (1992) 319-323
26. Jensen T., Bjerre-Knudsen J., Feldt-Rasmussen B., and Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1 (1989) 461-463
27. Legato M.J., Gelzer A., Goland R., Ebner S.A., Rajan S., Villagra V., and Kosowski M. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 3 (2006) 131-158
28. Ulmer H., Kelleher C., Diem G., and Concin H. Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health (Larchmt) 13 (2004) 41-53
29. Tanko L.B., Bagger Y.Z., Qin G., Alexandersen P., Larsen P.J., and Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 111 (2005) 1883-1890
30. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359